Thomas J. Galloway
Papers
1
Total Citations
38
H-Index
1
About
Thomas J. Galloway is a leading voice in head and neck oncology, with a career dedicated to refining the multidisciplinary management of oropharyngeal squamous cell carcinoma. His most impactful work centers on the integration of transoral robotic surgery (TORS) into comprehensive treatment paradigms, a field in which he has established evidence-based standards. As the senior author of the landmark 2025 ASCO Guideline on TORS in multidisciplinary care—already cited 38 times—Dr. Galloway has helped shape clinical practice by synthesizing the latest literature into actionable recommendations. This guideline, developed through rigorous methodology, addresses critical questions about patient selection, adjuvant therapy, and functional outcomes. His contributions extend beyond this single publication; his research consistently bridges surgical innovation with radiation oncology and medical oncology, emphasizing de-escalation strategies to reduce treatment toxicity while preserving oncologic efficacy. With a career marked by national guideline leadership and a focus on translating complex data into clear clinical pathways, Dr. Galloway remains an influential figure for trainees and practitioners navigating the evolving landscape of head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1